These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 7814142

  • 1. Nuclear DNA content and chromatin texture in multidrug-resistant human leukemic cell lines.
    Dufer J, Millot-Broglio C, Oum'Hamed Z, Liautaud-Roger F, Joly P, Desplaces A, Jardillier JC.
    Int J Cancer; 1995 Jan 03; 60(1):108-14. PubMed ID: 7814142
    [Abstract] [Full Text] [Related]

  • 2. Analysis of DNA content in multidrug-resistant cells by image and flow cytometry.
    Palissot V, Liautaud-Roger F, Carpentier Y, Dufer J.
    Cell Prolif; 1996 Oct 03; 29(10):549-59. PubMed ID: 9051118
    [Abstract] [Full Text] [Related]

  • 3. Pirarubicin nuclear uptake does not correlate with its induced cell death effect during reversal of multidrug resistance by quinine in human K562 and CEM leukemic cells.
    Morjani H, Belhoussine R, Lahlil R, Manfait M.
    Eur J Haematol; 1998 Oct 03; 61(4):240-9. PubMed ID: 9820630
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line.
    Zalcberg JR, Hu XF, Wall DM, Mirski S, Cole S, Nadalin G, De Luise M, Parkin JD, Vrazas V, Campbell L.
    Int J Cancer; 1994 May 15; 57(4):522-8. PubMed ID: 7514153
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nuclear chromatin texture and sensitivity to DNase I in human leukaemic CEM cells incubated with nanomolar okadaic acid.
    Yatouji S, Liautaud-Roger F, Dufer J.
    Cell Prolif; 2000 Feb 15; 33(1):51-62. PubMed ID: 10741644
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H, Genne P, Kadhim S, Bibeau L, Duchamp O, Ouellet F, deMuys JM, Bouffard DY, Attardo G.
    Cancer Chemother Pharmacol; 2002 Dec 15; 50(6):490-6. PubMed ID: 12451476
    [Abstract] [Full Text] [Related]

  • 11. Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?
    Hoffman MM, Wei LY, Roepe PD.
    J Gen Physiol; 1996 Oct 15; 108(4):295-313. PubMed ID: 8894978
    [Abstract] [Full Text] [Related]

  • 12. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.
    Efferth T, Davey M, Olbrich A, Rücker G, Gebhart E, Davey R.
    Blood Cells Mol Dis; 2002 Oct 15; 28(2):160-8. PubMed ID: 12064912
    [Abstract] [Full Text] [Related]

  • 13. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.
    Schuurhuis GJ, Broxterman HJ, Ossenkoppele GJ, Baak JP, Eekman CA, Kuiper CM, Feller N, van Heijningen TH, Klumper E, Pieters R.
    Clin Cancer Res; 1995 Jan 15; 1(1):81-93. PubMed ID: 9815890
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxic effect of the cyclosporin PSC 833 in multidrug-resistant leukaemia cells with increased expression of P-glycoprotein.
    Lehne G, Rugstad HE.
    Br J Cancer; 1998 Sep 15; 78(5):593-600. PubMed ID: 9744497
    [Abstract] [Full Text] [Related]

  • 15. Selectively induced high MRP gene expression in multidrug-resistant human HL60 leukemia cells.
    Wada H, Saikawa Y, Niida Y, Nishimura R, Noguchi T, Matsukawa H, Ichihara T, Koizumi S.
    Exp Hematol; 1999 Jan 15; 27(1):99-109. PubMed ID: 9923448
    [Abstract] [Full Text] [Related]

  • 16. Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.
    Wang YH, Imai Y, Shiseki M, Tanaka J, Motoji T.
    Leuk Res; 2018 Apr 15; 67():99-108. PubMed ID: 29482174
    [Abstract] [Full Text] [Related]

  • 17. Attenuated JNK signaling in multidrug-resistant leukemic cells. Dual role of MAPK in cell survival.
    Cerezo D, Ruiz-Alcaraz AJ, Lencina-Guardiola M, Cánovas M, García-Peñarrubia P, Martínez-López I, Martín-Orozco E.
    Cell Signal; 2017 Jan 15; 30():162-170. PubMed ID: 27940051
    [Abstract] [Full Text] [Related]

  • 18. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells.
    Gollapudi S, Kim CH, Tran BN, Sangha S, Gupta S.
    Cancer Chemother Pharmacol; 1997 Jan 15; 40(2):150-8. PubMed ID: 9182837
    [Abstract] [Full Text] [Related]

  • 19. Confocal scanning microspectrofluorometry reveals specific anthracyline accumulation in cytoplasmic organelles of multidrug-resistant cancer cells.
    Belhoussine R, Morjani H, Millot JM, Sharonov S, Manfait M.
    J Histochem Cytochem; 1998 Dec 15; 46(12):1369-76. PubMed ID: 9815278
    [Abstract] [Full Text] [Related]

  • 20. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S, Mukherjee SK, Taylor BJ, Ivy SP, Fu CH, Ardi VC, Avramis VI.
    Anticancer Res; 2000 Dec 15; 20(1A):139-50. PubMed ID: 10769646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.